Dyax Corp (DYAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DYAX | LGND | CRSP | ||
| Company | Dyax Corp | Ligand Pharm | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.04 | 288.09 | 59.72 | ||
| High | 38.04 | 289.98 | 62.54 | ||
| Low | 38.04 | 285.87 | 58.89 | ||
| Last | 38.04 | 288.79 | 59.58 | ||
| Change | -0.37 | +1.40 | +1.46 | ||
| Percent Change | -0.96% | +0.49% | +2.51% | ||
| Volume | 400 | 69,399 | 1,857,534 | ||
| 20-Day Average Volume | 3,916,305 | 264,630 | 1,537,389 | ||
| Previous | 38.41 | 287.39 | 58.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.87 | 293.08 | 52.64 | ||
| 20-Day Raw Stochastic | 51.85% | 18.19% | 83.89% | ||
| 20-Day Relative Strength | 66.28 | 49.51 | 62.97 | ||
| Weighted Alpha | +77.40 | +81.78 | +13.67 | ||
| Today's Opinion | N/A | 40% Buy | 40% Buy | ||
| Yesterday's Opinion | N/A | 56% Buy | 24% Buy | ||
| Last Month's Opinion | N/A | 88% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.13% since 01/15/16 | -2.01% since 08/14/26 | +11.76% since 08/14/26 | ||
| Low | 38.04 on 01/22/16 | 282.25 on 08/19/26 | 51.80 on 08/18/26 | ||
| High | 38.56 on 01/21/16 | 298.29 on 08/17/26 | 62.53 on 08/21/26 | ||
| 1-Month | |||||
| %Chg | +0.93% since 12/22/15 | -5.50% since 07/21/26 | +24.30% since 07/21/26 | ||
| Low | 37.48 on 12/28/15 | 282.25 on 08/19/26 | 45.89 on 07/28/26 | ||
| High | 38.56 on 01/21/16 | 317.49 on 08/06/26 | 62.53 on 08/21/26 | ||
| 3-Month | |||||
| %Chg | +42.74% since 10/22/15 | +29.92% since 05/21/26 | +19.94% since 05/21/26 | ||
| Low | 26.53 on 10/23/15 | 221.87 on 05/22/26 | 45.89 on 07/28/26 | ||
| High | 38.56 on 01/21/16 | 326.63 on 07/08/26 | 63.45 on 07/06/26 | ||
| 6-Month | |||||
| %Chg | +41.78% since 07/22/15 | +56.90% since 02/20/26 | +11.95% since 02/20/26 | ||
| Low | 17.40 on 09/29/15 | 178.72 on 02/26/26 | 44.12 on 03/30/26 | ||
| High | 38.56 on 01/21/16 | 326.63 on 07/08/26 | 63.45 on 07/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,638,660 | 5,729,408 | 5,619,797 | ||
| Shares Outstanding, K | 146,360 | 19,936 | 96,693 | ||
| Annual Sales, $M | 81,720,000 | 268,090,000 | 3,510,000 | ||
| Annual Net Income, $M | -11,880,000 | 124,450,000 | -581,600,000 | ||
| Last Qtr Sales, $M | 24,730,000 | 63,690,000 | 10,180,000 | ||
| Last Qtr Income, $M | -11,700,000 | 48,510,000 | -91,150,000 | ||
| 60-Month Beta | 1.41 | 1.13 | 1.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 10/28/15 | 2.37 on 08/06/26 | -0.94 on 08/03/26 | ||
| Latest Earnings Date | 02/23/16 | 11/05/26 | 11/09/26 | ||
| Most Recent Dividend | N/A | 2.500 on 04/03/07 | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 31.09 | 0.00 | ||